oral etanercept (OPRX-106) - Protalix
Protalix: Corporate Presentation (Protalix) - Jul 2, 2014 - Anticipated initiation of P1 trial for treatment of autoimmune diseases in 2014 
Anticipated new P1 trial • Anticipated trial initiation date Biosimilar
http://phx.corporate-ir.net/phoenix.zhtml?c=101161&p=irol-presentations
 
Jul 2, 2014
 
.
 
60f7db14-7cb0-450a-a1f1-a2ab16d9233a.jpg